Dermatology patients' knowledge and concerns regarding their immunomodulatory medication during the COVID-19 pandemic
- PMID: 32356601
- PMCID: PMC7262014
- DOI: 10.1111/dth.13488
Dermatology patients' knowledge and concerns regarding their immunomodulatory medication during the COVID-19 pandemic
Conflict of interest statement
The authors declare no conflicts of interest.
Comment on
-
Advice regarding COVID-19 and use of immunomodulators, in patients with severe dermatological diseases.Australas J Dermatol. 2020 May;61(2):158-159. doi: 10.1111/ajd.13295. Epub 2020 Apr 14. Australas J Dermatol. 2020. PMID: 32219857 Free PMC article. No abstract available.
References
-
- International League of Dermatological Societies Guidance on the use of systemic therapy for patients with psoriasis/atopic dermatitis during the COVID‐19 (Sars‐Cov‐2, coronavirus) pandemic; April 2020. ILDS.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
